Generic pharma producer Sopharma (3JR BU) is proposing 42% y/y higher dividend per share of BGN 0.10 from 2016 profits, according to forthcoming annual shareholders meeting. This is the first dividend raise since 2010. The decision is to be approved at the annual shareholders meeting scheduled for June 2nd, 2017. The proposed dividend yields 2.5% at current market quotes.

Sopharma Q1 results keep the pace

Sopharma booked 12% y/y rise in sales in Q1’17 on strong exports to Russia, according to the Company’s unconsolidated financial statement for Q1 2017. Sales added 12.3% y/y to BGN 46.6m on 24.3% y/y rise in exports to BGN BGN 29.7m and 4.1% y/y drop in domestic sales to BGN 16.9m.

Exports to Russia were key growth driver where revenue surged 32.1% y/y to BGN 17.3m. The Company’s management said the positive sentiment in Russia continues in April and is positive on H1 performance as well.

Sustaining results also in April

Sopharma announced top line expansion sustained at 12% y/y for the Jan-Apr. 2017, according to the Company’s regular monthly announcement. Exports for the period are up 18% y/y, while domestic sales add 1% y/y. Most of the top line expansion is due to improvements on the Russian market which is 2nd most important for Sopharma.

Capital 50 ranking of the best public companies

Sopharma was ranked Top 5 in this year Capital 50 ranking of the Best Public Companies. Criteria for ranking are revenues and its expansion rate, market capitalization and growth, liquidity and margin. Data is being calculated from the annual financial statements.

Sopharma will be present at Bulgarian Capital Market Day in London

Sopharma will be presented at a special Bulgarian Capital Market Day for CEE-focused investors that will take place at EBRD headquarters in London on 18 May 2017 presenting for one day an insight in CEE regional development and Bulgarian capital market in-depth.

The event is organized by the Bulgarian Stock Exchange, kindly hosted by EBRD and in partnership with Citibank, ELANA Trading, Sofia International Securities.

Participants will hear senior experts’ presentation on CEE and Bulgaria macroeconomic status and will get an in-depth overview of the Bulgarian capital market from Ivan Takev, Executive Director of Bulgarian Stock Exchange.

Check the latest equity research reports by ELANA Trading